These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20618330)

  • 1. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.
    Ben-Ami R; Lewis RE; Kontoyiannis DP
    Br J Haematol; 2010 Aug; 150(4):406-17. PubMed ID: 20618330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus fumigatus: contours of an opportunistic human pathogen.
    McCormick A; Loeffler J; Ebel F
    Cell Microbiol; 2010 Nov; 12(11):1535-43. PubMed ID: 20716206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillosis and stem cell transplantation: An overview of experimental pathogenesis studies.
    Al-Bader N; Sheppard DC
    Virulence; 2016 Nov; 7(8):950-966. PubMed ID: 27687755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tools, progress and questions in the molecular study of Aspergillus fumigatus and invasive aspergillosis].
    Latgé JP; Paris S; Sarfati J; Debeaupuis JP; Diaquin M; Girardin H
    Pathol Biol (Paris); 1994 Sep; 42(7):632-9. PubMed ID: 7877854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench.
    Chai LY; Vonk AG; Kullberg BJ; Netea MG
    Future Microbiol; 2011 Jan; 6(1):73-83. PubMed ID: 21162637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis.
    Orciuolo E; Stanzani M; Canestraro M; Galimberti S; Carulli G; Lewis R; Petrini M; Komanduri KV
    J Leukoc Biol; 2007 Oct; 82(4):839-48. PubMed ID: 17626149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility to Aspergillus fumigatus infections.
    Ok M; Einsele H; Loeffler J
    Int J Med Microbiol; 2011 Jun; 301(5):445-52. PubMed ID: 21550849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspergillus fumigatus: from saprophytism to virulence. Phenotypic and genotypic biodiversity].
    Grillot R; Mondon P; Brenier MP; Ambroise-Thomas P
    Ann Pharm Fr; 1996; 54(2):68-72. PubMed ID: 8734331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to Aspergillus fumigatus infections.
    Rivera A; Hohl T; Pamer EG
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):47-9. PubMed ID: 16399584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinate against aspergillosis! A call to arms of the immune system.
    Stevens DA
    Clin Infect Dis; 2004 Apr; 38(8):1131-6. PubMed ID: 15095219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model.
    Kupfahl C; Heinekamp T; Geginat G; Ruppert T; Härtl A; Hof H; Brakhage AA
    Mol Microbiol; 2006 Oct; 62(1):292-302. PubMed ID: 16956378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of hypoxic microenvironments during invasive aspergillosis.
    Wezensky SJ; Cramer RA
    Med Mycol; 2011 Apr; 49 Suppl 1(Suppl 1):S120-4. PubMed ID: 20560863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern recognition receptors and their role in invasive aspergillosis.
    Gresnigt MS; Netea MG; van de Veerdonk FL
    Ann N Y Acad Sci; 2012 Dec; 1273():60-7. PubMed ID: 23230838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into invasive aspergillosis--from the pathogen to the disease.
    Binder U; Lass-Flörl C
    Curr Pharm Des; 2013; 19(20):3679-88. PubMed ID: 23278533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to invade a susceptible host: cellular aspects of aspergillosis.
    Krappmann S
    Curr Opin Microbiol; 2016 Dec; 34():136-146. PubMed ID: 27816786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspergillus fumigatus does not require fatty acid metabolism via isocitrate lyase for development of invasive aspergillosis.
    Schöbel F; Ibrahim-Granet O; Avé P; Latgé JP; Brakhage AA; Brock M
    Infect Immun; 2007 Mar; 75(3):1237-44. PubMed ID: 17178786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive aspergillosis in 2002: an update.
    Kontoyiannis DP; Bodey GP
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):161-72. PubMed ID: 11957017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspergillus fumigatus morphology and dynamic host interactions.
    van de Veerdonk FL; Gresnigt MS; Romani L; Netea MG; Latgé JP
    Nat Rev Microbiol; 2017 Nov; 15(11):661-674. PubMed ID: 28919635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts.
    Chignard M; Balloy V; Sallenave JM; Si-Tahar M
    Clin Immunol; 2007 Sep; 124(3):238-43. PubMed ID: 17604224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillus fumigatus meningitis in immunosuppressed patients; diagnosis, management, prevention and control.
    Preotescu L; Popa GL; Motoi M; Streinu-Cercel A; Popa MI
    Roum Arch Microbiol Immunol; 2009; 68(2):95-9. PubMed ID: 20361528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.